Ross Osborn
Stock Analyst at Cantor Fitzgerald
(1.82)
# 2,881
Out of 4,818 analysts
104
Total ratings
26.04%
Success rate
-8.83%
Average return
Main Sectors:
Stocks Rated by Ross Osborn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NNOX Nano-X Imaging | Maintains: Overweight | $12 → $9 | $5.10 | +76.47% | 11 | Apr 1, 2025 | |
| SMTI Sanara MedTech | Reiterates: Overweight | $46 | $30.22 | +52.22% | 6 | Mar 26, 2025 | |
| LUCD Lucid Diagnostics | Reiterates: Overweight | $2 | $1.30 | +54.44% | 5 | Mar 26, 2025 | |
| ELUT Elutia | Reiterates: Overweight | $8 | $2.24 | +257.14% | 10 | Mar 7, 2025 | |
| AXGN Axogen | Reiterates: Overweight | $24 | $15.68 | +53.06% | 3 | Mar 5, 2025 | |
| NPCE NeuroPace | Maintains: Overweight | $19 → $20 | $10.93 | +82.98% | 5 | Mar 5, 2025 | |
| MDXG MiMedx Group | Reiterates: Overweight | $13 | $6.77 | +92.02% | 3 | Feb 27, 2025 | |
| SIBN SI-BONE | Reiterates: Overweight | $25 | $13.89 | +79.99% | 8 | Feb 25, 2025 | |
| CERS Cerus | Reiterates: Overweight | $4 | $1.37 | +191.97% | 4 | Feb 21, 2025 | |
| PRE Prenetics Global | Reiterates: Overweight | $9 | $4.60 | +95.65% | 7 | Jan 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $8 | $5.70 | +40.35% | 5 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $4.48 | +100.89% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $21 | $9.75 | +115.38% | 10 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $16 | $6.03 | +165.34% | 4 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $14 | $6.11 | +129.13% | 2 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $96 | $89.54 | +7.21% | 1 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $3.5 | $1.17 | +199.15% | 5 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $2.5 | $0.49 | +413.66% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.15 | - | 7 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $4.44 | +12.74% | 2 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $8.61 | $0.77 | +1,018.18% | 2 | Aug 18, 2023 |
Nano-X Imaging
Apr 1, 2025
Maintains: Overweight
Price Target: $12 → $9
Current: $5.10
Upside: +76.47%
Sanara MedTech
Mar 26, 2025
Reiterates: Overweight
Price Target: $46
Current: $30.22
Upside: +52.22%
Lucid Diagnostics
Mar 26, 2025
Reiterates: Overweight
Price Target: $2
Current: $1.30
Upside: +54.44%
Elutia
Mar 7, 2025
Reiterates: Overweight
Price Target: $8
Current: $2.24
Upside: +257.14%
Axogen
Mar 5, 2025
Reiterates: Overweight
Price Target: $24
Current: $15.68
Upside: +53.06%
NeuroPace
Mar 5, 2025
Maintains: Overweight
Price Target: $19 → $20
Current: $10.93
Upside: +82.98%
MiMedx Group
Feb 27, 2025
Reiterates: Overweight
Price Target: $13
Current: $6.77
Upside: +92.02%
SI-BONE
Feb 25, 2025
Reiterates: Overweight
Price Target: $25
Current: $13.89
Upside: +79.99%
Cerus
Feb 21, 2025
Reiterates: Overweight
Price Target: $4
Current: $1.37
Upside: +191.97%
Prenetics Global
Jan 16, 2025
Reiterates: Overweight
Price Target: $9
Current: $4.60
Upside: +95.65%
Jan 13, 2025
Reiterates: Overweight
Price Target: $8
Current: $5.70
Upside: +40.35%
Jan 7, 2025
Initiates: Overweight
Price Target: $9
Current: $4.48
Upside: +100.89%
Dec 24, 2024
Reiterates: Overweight
Price Target: $21
Current: $9.75
Upside: +115.38%
Nov 5, 2024
Reiterates: Overweight
Price Target: $16
Current: $6.03
Upside: +165.34%
Oct 23, 2024
Reiterates: Overweight
Price Target: $14
Current: $6.11
Upside: +129.13%
Oct 15, 2024
Initiates: Neutral
Price Target: $96
Current: $89.54
Upside: +7.21%
Aug 8, 2024
Reiterates: Overweight
Price Target: $3.5
Current: $1.17
Upside: +199.15%
May 16, 2024
Reiterates: Overweight
Price Target: $2.5
Current: $0.49
Upside: +413.66%
Apr 12, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.15
Upside: -
Mar 1, 2024
Reiterates: Overweight
Price Target: $5
Current: $4.44
Upside: +12.74%
Aug 18, 2023
Reiterates: Neutral
Price Target: $8.61
Current: $0.77
Upside: +1,018.18%